Bartelink H - Search Results

1

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation.

van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. van der Heijden M, et al. Among authors: bartelink h. Front Oncol. 2020 Jan 10;9:1470. doi: 10.3389/fonc.2019.01470. eCollection 2019. Front Oncol. 2020. PMID: 31998639 Free PMC article.

2

Optimized radiotherapy for head and neck cancer.

Russell NS, Bartelink H. Russell NS, et al. Among authors: bartelink h. Curr Opin Oncol. 1992 Jun;4(3):491-8. doi: 10.1097/00001622-199206000-00011. Curr Opin Oncol. 1992. PMID: 1386755

3

The value of staging of neck nodes in patients treated with radiotherapy.

van den Brekel MW, Bartelink H, Snow GB. van den Brekel MW, et al. Among authors: bartelink h. Radiother Oncol. 1994 Sep;32(3):193-6. doi: 10.1016/0167-8140(94)90017-5. Radiother Oncol. 1994. PMID: 7816937 Review. No abstract available.

4

Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects.

Verheij M, van Blitterswijk WJ, Bartelink H. Verheij M, et al. Among authors: bartelink h. Acta Oncol. 1998;37(6):575-81. doi: 10.1080/028418698430287. Acta Oncol. 1998. PMID: 9860316

5

Towards prediction and modulation of treatment response.

Bartelink H, Begg A, Martin JC, van Dijk M, van 't Veer L, van der Vaart P, Verheij M. Bartelink H, et al. Radiother Oncol. 1999 Jan;50(1):1-11. doi: 10.1016/s0167-8140(99)00009-2. Radiother Oncol. 1999. PMID: 10225551 Review.

6

Translational research offers individually tailored treatments for cancer patients.

Bartelink H, Begg AC, Martin JC, van Dijk M, Moonen L, van 't Veer LJ, Van de Vaart P, Verheij M. Bartelink H, et al. Cancer J Sci Am. 2000 Jan-Feb;6(1):2-10. Cancer J Sci Am. 2000. PMID: 10696731 Review.

7

Radiation-induced apoptosis.

Verheij M, Bartelink H. Verheij M, et al. Among authors: bartelink h. Cell Tissue Res. 2000 Jul;301(1):133-42. doi: 10.1007/s004410000188. Cell Tissue Res. 2000. PMID: 10928286 Review.

8

Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?

Schornagel JH, Verheij M, Bartelink H. Schornagel JH, et al. Among authors: bartelink h. Curr Oncol Rep. 2001 Jan;3(1):1-2. doi: 10.1007/s11912-001-0034-3. Curr Oncol Rep. 2001. PMID: 11123863 No abstract available.

9

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H. Moonen L, et al. Among authors: bartelink h. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10. doi: 10.1016/s0360-3016(00)01503-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286838

10

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M. Ong F, et al. Among authors: bartelink h. Radiother Oncol. 2001 Nov;61(2):169-75. doi: 10.1016/s0167-8140(01)00421-2. Radiother Oncol. 2001. PMID: 11690683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page